EXHIBIT 10.42 December 18, 2001 Amgen Inc. ("Amgen") One Amgen Center Drive Building 29 Thousand Oaks, CA 91320 Attention: Philip Tagari Associate Director, Research RE: AMENDMENT NUMBER 2 TO TECHNOLOGY ACCESS AGREEMENT Dear Phil: We have realized...Technology Access Agreement • March 29th, 2002 • Caliper Technologies Corp • Laboratory analytical instruments
EXHIBIT 10.44 February 28, 2002 Craig Muir Vice President, Platform Technology Millennium Pharmaceuticals, Inc. 75 Sidney Street Cambridge, MA 02139 RE: Amendment Number 2 to Technology Access and Applications Development Agreement between Millennium...Technology Access and Applications Development Agreement • March 29th, 2002 • Caliper Technologies Corp • Laboratory analytical instruments
EXHIBIT 10.40 August 9, 2001 Calvin Y.H. Chow c/o Caliper Technologies 605 Fairchild Drive Mountain View, CA 94043-2234 Dear Calvin: This letter sets forth the substance of the separation agreement (the "Agreement") that Caliper Technologies (the...Separation Agreement • March 29th, 2002 • Caliper Technologies Corp • Laboratory analytical instruments • California
